Zacks Research Brokers Lower Earnings Estimates for TSE:BHC

Bausch Health Companies Inc. (TSE:BHC) – Equities researchers at Zacks Research cut their FY2025 earnings estimates for shares of Bausch Health Companies in a research report issued on Monday, January 20th. Zacks Research analyst R. Department now expects that the company will earn $6.06 per share for the year, down from their prior estimate of $6.13. The consensus estimate for Bausch Health Companies’ current full-year earnings is $5.55 per share. Zacks Research also issued estimates for Bausch Health Companies’ Q4 2025 earnings at $1.68 EPS, Q4 2026 earnings at $1.82 EPS and FY2026 earnings at $7.02 EPS.

Bausch Health Companies (TSE:BHC) last posted its earnings results on Wednesday, October 30th. The company reported C$1.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of C$1.43 by C$0.10. The business had revenue of C$3.42 billion during the quarter, compared to analyst estimates of C$3.36 billion. Bausch Health Companies had a negative return on equity of 2,304.54% and a negative net margin of 5.12%.

Separately, Evercore ISI upgraded shares of Bausch Health Companies to a “hold” rating in a research note on Tuesday, October 15th.

Bausch Health Companies Stock Up 1.1 %

Shares of TSE:BHC opened at C$11.24 on Thursday. The company has a market capitalization of C$4.13 billion, a price-to-earnings ratio of -6.42, a price-to-earnings-growth ratio of 0.21 and a beta of 0.77. The company has a 50 day moving average of C$11.24 and a two-hundred day moving average of C$10.33. Bausch Health Companies has a 52-week low of C$5.45 and a 52-week high of C$15.43. The company has a quick ratio of 0.58, a current ratio of 1.19 and a debt-to-equity ratio of 7,583.76.

Bausch Health Companies Company Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.